Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18068794 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL16491142 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL87465 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL8753814 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL15502205 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL8033989 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL7521085 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL39378 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL177611 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 | |
| SCHEMBL30933451 | 1.00 | POLB (0.50) | POLBMEN1KMT2AALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1662631-A | Method for removing metal ions from crude oil | BP EXPLORATION OPERATING (GB) | 2005-08-31 | — | — | CN | claimed |
| EP-0800611-B1 | OIL AND GAS FIELD CHEMICALS | BP CHEM INT LTD (GB) | 1998-09-23 | — | — | EP | claimed |
| US-5690174-A | ANTISCALE | BP CHEMICALS LIMITED (GB) | 1997-11-25 | — | — | US | claimed |
| EP-0800611-A1 | OIL AND GAS FIELD CHEMICALS | BP Chemicals Limited (GB) | 1997-10-15 | — | — | EP | claimed |
| WO-1996022451-A1 | OIL AND GAS FIELD CHEMICALS | BP CHEMICALS LIMITED (GB) | 1996-07-25 | — | — | WO | claimed |
| CN-1980985-B | Pyrrolidone-carboxyl modified polysiloxanes having water and detergent solubility and water-in-oil emulsion capability | ICI AMERICA INC | 2010-11-03 | — | — | CN | disclosed |
| US-7553819-B2 | Multivalent inhibitors of serum amyloid P component | THERACARB INC. (CA) | 2009-06-30 | — | — | US | disclosed |
| US-7553819-B2 | Multivalent inhibitors of serum amyloid P component | THERACARB INC. (CA) | 2009-06-30 | — | — | US | disclosed |
| CN-1980985-A | Pyrrolidone-carboxyl modified polysiloxanes having water and detergent solubility and water-in-oil emulsion capability | ICI AMERICA INC (US) | 2007-06-13 | — | — | CN | disclosed |
| US-20070042936-A1 | Multivalent inhibitors of serum amyloid p component | THERACARB INC. | 2007-02-22 | — | — | US | disclosed |
| US-20070042936-A1 | Multivalent inhibitors of serum amyloid p component | THERACARB INC. | 2007-02-22 | — | — | US | disclosed |
| CN-1272419-C | Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants | ICI AMERICALS INC (US) | 2006-08-30 | — | — | CN | disclosed |
| CN-1662631-A | Method for removing metal ions from crude oil | BP EXPLORATION OPERATING (GB) | 2005-08-31 | — | — | CN | disclosed |
| WO-2004099173-A1 | MULTIVALENT INHIBITORS OF SERUM AMYLOID P COMPONENT | THERACARB INC. (CA) | 2004-11-18 | — | — | WO | disclosed |
| CN-1535309-A | Mixed polyalkylene glycol hydroxyalkyl isostearamides as rheology adjuvants | ICI | 2004-10-06 | — | — | CN | disclosed |
| EP-0912815-B1 | USE OF OIL AND GAS FIELD CHEMICALS | BP CHEM INT LTD (GB) | 2001-09-26 | — | — | EP | disclosed |
| US-6225263-B1 | INJECTING INTO THE FORMATION, PREFERABLY IN THE FORM OF AN AQUEOUS SOLUTION, AT LEAST ONE MONO ALKYL ETHER OF POLYETHYLENE GLYCOL IN WHICH THE ALKYL GROUP HAS 3-5 CARBONS AND THE POLYETHYLENE GLYCOL CONTAINS 3-6 ETHYLENE OXY UNITS | BP CHEMICALS LIMITED (GB) | 2001-05-01 | — | — | US | disclosed |
| EP-0912815-A1 | USE OF OIL AND GAS FIELD CHEMICALS | BP Chemicals Limited (GB) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998002636-A1 | USE OF OIL AND GAS FIELD CHEMICALS | BP CHEMICALS LIMITED (GB) | 1998-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042936-A1 | Multivalent inhibitors of serum amyloid p component | IAPP, APP, PRNP | POLB 3526/4885MEN1 3324/4885KMT2A 3940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.